Placement Risk Assessment
SNF placement risk modeling identifies patients whose home circumstances and functional status suggest facility support, informing decisions the care team makes with the patient.
Custom Software
AI Post-Discharge Risk Prediction Software Development
AI post-discharge risk prediction software applies machine learning to discharge disposition, home circumstances, medication complexity, and follow-up engagement to identify patients needing intensified support after leaving hospital. It functions as decision support only: the care team decides all placement, referral, and follow-up, and no service is denied by software.
Readmission prediction asks who might come back. Post-discharge risk prediction asks a different and more actionable question: who needs what support once they are already home. Taction Software builds AI post-discharge risk tooling for the transitional care window, where the intervention is outreach, home services, and placement support rather than inpatient planning.
Tell Us Your Requirements
Our experts are ready to understand your business goals.
Trusted Partners
Trusted by Industry Leaders Worldwide
Recognition
Awards & Recognitions
What Is AI Post-Discharge Risk Prediction
AI post-discharge risk prediction refers to machine learning applied to the period after hospital discharge: modeling which patients face elevated risk of deterioration, medication problems, or care breakdown, and which post-acute setting supports them best. It differs from inpatient readmission scoring by operating on the discharged population with different data, including whether follow-up appointments were attended and whether prescriptions were filled. Placement and referral decisions remain entirely with the care team. This work sits inside our broader healthcare AI practice.
Home Health Referral Support
Home health referral tooling identifies likely candidates and prepares referral documentation, with the clinician determining medical necessity and ordering services.
Follow-Up Prioritization
Follow-up prioritization ranks the discharged panel so limited transitional care capacity reaches patients most likely to benefit from contact.
Medication Risk Monitoring
Post-discharge medication problems are a leading breakdown point, connecting with AI medication reconciliation for regimen review.
Engagement Signal Tracking
Unfilled prescriptions and missed appointments are strong signals. Engagement tracking surfaces them while there is still time to intervene.
Decision Support Boundaries
Every output carries clinical decision support framing. The software does not determine placement, deny services, authorize referrals, or make care decisions.
Core AI Post-Discharge Risk Services
Our AI post-discharge risk services cover data integration, risk modeling, outreach workflow, referral automation, and monitoring. The defining constraint in this window is that the patient has left your building, so data becomes sparse exactly when risk peaks. Useful systems therefore combine discharge-time features with whatever post-discharge signal is obtainable, including pharmacy fill data and appointment attendance. Engagements typically open with a review of available post-discharge data and existing transitional care capacity. Deliverables are structured so case management, home health liaison, and IT stakeholders can review independently.
01
Discharge Data Assembly
We assemble discharge disposition, functional status, social circumstances, and medication complexity into a risk assessment produced at or near discharge.
02
Post-Discharge Signal Integration
We integrate obtainable post-discharge signals including pharmacy fill status and appointment attendance, which are frequently the earliest available warning.
03
Risk Model Development
Development produces models validated on your discharged population, with subgroup reporting across insurance status, language, and living situation.
04
Outreach Workflow Design
Outreach connects with AI patient outreach capabilities, with contact prioritization matched to your actual staffing capacity.
05
Referral Preparation Automation
Referral tooling prepares home health and post-acute documentation from clinical data, reducing manual assembly while clinicians authorize every referral.
06
Social Risk Context
Post-discharge outcomes depend heavily on circumstances, connecting with AI SDOH analytics for social risk context.
Benefits of AI Post-Discharge Risk Prediction
The benefits of AI post-discharge risk prediction concentrate in prioritized outreach, earlier problem detection, and better prepared referrals. Transitional care teams typically work from discharge lists ordered by date rather than risk, which means capacity is spent evenly across a population with very uneven need. Engagement signals also arrive earlier than clinical deterioration does. We publish no figures on readmission, mortality, or placement outcomes, because those depend entirely on your capacity and population.
Prioritized Outreach Capacity
Risk-ranked panels direct limited transitional care contact toward patients most likely to benefit rather than working chronologically through a list.
Earlier Problem Detection
Unfilled prescriptions and missed appointments surface breakdown before clinical deterioration, when a phone call can still resolve the issue.
Better Prepared Referrals
Automated referral documentation reduces assembly time and incomplete submissions, which delay home health starts during the highest-risk period.
Informed Placement Discussions
Structured risk and functional data support placement conversations with patients and families, with decisions made jointly rather than by algorithm.
Chronic Care Continuity
Structured handoff supports enrollment into longer-term management, connecting with chronic care management programs.
Remote Monitoring Targeting
Risk data identifies candidates for monitoring programs, connecting with remote patient monitoring where enrollment is clinician-determined.
Our AI Post-Discharge Risk Process
We deliver AI post-discharge risk projects in gated phases so clinical stakeholders approve direction before engineering cost accumulates. Discovery establishes intended use, obtainable post-discharge data, and existing outreach capacity, since prioritization only helps if outreach exists to prioritize. Development is iterative with case management review. We give particular attention to equity validation, because post-discharge risk is driven substantially by social circumstance, and models can direct scarce support away from patients whose disadvantage the data underrepresents.
Discovery and Capacity Assessment
Discovery defines intended use and assesses outreach capacity, since risk ranking without follow-up capability produces a report rather than an intervention.
Data Availability Assessment
We evaluate obtainable post-discharge data including pharmacy and scheduling access, which varies considerably and determines what the model can detect.
Model Development and Validation
Development runs to held-out validation with performance reported by insurance status, language, living situation, and discharge disposition.
Equity Gate Review
Models pass an equity review before deployment, because social-circumstance-driven risk can encode disadvantage as low engagement rather than high need.
Outreach Design With Case Management
We design prioritization and contact workflow with case managers, since the people making calls know which signals actually predict a productive conversation.
Rollout and Ongoing Support
Rollout expands by service line with performance dashboards, clinical review, and continuing subgroup monitoring for the life of the deployment.
Technology and Compliance
Post-discharge risk prediction handles PHI and, where social determinants and pharmacy data are used, sensitive information requiring careful handling. Taction holds ISO 27001 certification and follows HIPAA-aligned engineering practice. Where risk output guides clinical management, SaMD classification may apply. The concern deserving most attention is that engagement signals can be misread: a patient who misses appointments because of transportation barriers looks identical in the data to a patient who is disengaged, and treating them the same way directs support away from the person who needs it more.
HIPAA-Aligned Engineering
Builds apply encryption in transit and at rest, role-based access, and complete audit logging. Our HIPAA compliance software development practice defines these controls.
SaMD and FDA Considerations
Risk output guiding management may trigger SaMD classification. Our FDA SaMD compliance services cover design history, validation, and change control.
Engagement Signal Interpretation
Engagement signals require careful interpretation, since barriers and disengagement look identical in data while requiring opposite responses.
Equity Validation Requirements
Equity validation is a required gate, because models can encode structural disadvantage as low engagement and direct support away from higher-need patients.
Post-Discharge Data Sourcing
Pharmacy data and external records carry their own access agreements and consent considerations, which we resolve during discovery rather than assuming availability.
Deployment Security
Deployments run on-premise, in your cloud tenancy, or hybrid, with network segmentation, signed container images, and documented penetration testing before release.
Why Choose Taction Software
Taction Software was founded in 2013 and has spent over 12 years building healthcare software, delivering more than 200 healthcare projects from four US offices in Chicago, Cheyenne, Austin, and Sacramento, with ISO 27001 certification. Our relevant judgment here is treating engagement signals as ambiguous rather than authoritative. A missed appointment is not evidence of disengagement, and models that treat it that way systematically underserve patients facing barriers. Our leadership brings more than 20 years of personal experience in the field.
01
Careful Signal Interpretation
We treat engagement data as ambiguous rather than conclusive, since barriers and disengagement are indistinguishable in the record but require opposite responses.
02
Capacity-Matched Design
We match prioritization output to your actual outreach capacity, since ranking a panel you cannot contact produces reporting rather than care.
03
Established Healthcare Focus
Founded in 2013, we have concentrated on healthcare rather than treating it as one vertical among several, producing depth in care coordination workflows.
04
EHR and Clinical Systems Depth
Our Voyant Health EHR and EMR work means EHR integration and referral write-back are handled by engineers with clinical systems experience.
05
Equity Validation Practice
We treat subgroup validation as a required gate rather than monitoring, which matters where social circumstance drives most of the risk signal.
06
Certified Security Posture
ISO 27001 certification and HIPAA-aligned engineering mean security controls are documented and auditable, supporting your vendor risk assessment efficiently.
Pricing
AI post-discharge risk pricing depends on scope, post-discharge data availability, outreach integration depth, and equity validation requirements. A discharge-time risk model with prioritized worklists costs considerably less than a system integrating pharmacy fill data, referral automation, and outreach workflow. We price after discovery, because external data access varies substantially and drives what the model can detect. Discovery produces an itemized, fixed-scope estimate with phase-level breakdown. Cloud infrastructure and third-party data licensing are separate from engineering and itemized clearly.
MVP or Single Module
An MVP producing risk-ranked discharge worklists from internal data typically runs $40,000 to $80,000, validating prioritization value before wider scope.
Full Platform Build
A full platform with post-discharge signal integration, referral automation, and outreach workflow typically falls between $80,000 and $200,000.
Enterprise Deployment
Enterprise engagements covering multi-facility rollout, external data integration, and equity validation start at $200,000 and scale with facility count.
Discovery Phase Scoping
Discovery is a paid, time-boxed phase producing an itemized estimate, architecture plan, and data availability assessment. It is separable so you can evaluate our work first.
Cost Drivers to Expect
External data access, referral automation depth, outreach integration, and equity validation are the largest variables, identified during discovery for budget planning.
Ongoing Support Costs
Post-launch recalibration, equity monitoring, data source maintenance, and support are quoted separately as a retainer sized to your discharge volume.
Get Started
If you are evaluating AI post-discharge risk prediction for outreach prioritization, placement support, or home health referral preparation, the fastest next step is a discovery call with our clinical engineering team. We will review available post-discharge data, assess outreach capacity, and return an itemized, fixed-scope estimate with an equity validation plan. Contact us to schedule that conversation.
FAQs
Frequently Asked Questions
Transitional care programs evaluating AI post-discharge risk prediction usually ask how it differs from readmission scoring, what data is available once a patient is home, and whether it could direct support away from patients who need it. The answers below reflect how we scope these projects.
Readmission scoring runs during the stay and asks who might return. Post-discharge risk operates on the discharged population with different data, including whether prescriptions were filled and appointments attended, and supports different decisions: placement, home health referral, and outreach prioritization rather than inpatient discharge planning.
Less than during the stay, which is the core constraint. Obtainable signals typically include pharmacy fill status, appointment attendance, and any monitoring or outreach contact. Access to external pharmacy data varies by agreement, so we confirm during discovery rather than assuming it is available.
Yes, if built carelessly, which is why equity validation is a required gate. A patient missing appointments because of transportation barriers looks identical to a disengaged patient, and models treating them the same underserve the person with barriers. We report subgroup performance and design signals to be interpreted rather than acted on mechanically.
An MVP producing risk-ranked worklists runs $40,000 to $80,000. A full platform with external signal integration and referral automation typically falls between $80,000 and $200,000. Enterprise multi-facility deployments start at $200,000. Discovery produces an itemized, fixed-scope estimate.
No. It surfaces functional status, home circumstances, and risk context to inform a conversation among the care team, patient, and family. Placement is a clinical and personal decision, and the software neither determines destination nor authorizes services in any configuration we build.
It can prepare referral documentation from clinical data, which removes manual assembly and reduces incomplete submissions. The clinician determines medical necessity and authorizes every referral. Automation handles paperwork rather than the ordering decision itself.